Provided by Tiger Trade Technology Pte. Ltd.

Abivax S.A.

92.88
-2.2200-2.33%
Post-market: 92.80-0.0800-0.09%19:44 EDT
Volume:644.33K
Turnover:60.29M
Market Cap:8.09B
PE:-15.70
High:95.82
Open:95.82
Low:92.58
Close:95.10
52wk High:148.83
52wk Low:69.81
Shares:87.05M
Float Shares:75.47M
Volume Ratio:0.47
T/O Rate:0.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.9176
EPS(LYR):-5.6758
ROE:-252.35%
ROA:-62.88%
PB:19.60
PE(LYR):-16.36

Loading ...

Movement Alert|Abivax S.A. Rises 5.15% in Regular Trading, Technical Rebound Continues as Phase 3 Safety Concerns Are Digested

Market Focus
·
Jun 17

Abivax SA Sponsored ADR (ABVX) Gets a Buy from Guggenheim

TIPRANKS
·
Jun 16

Analysts Are Bullish on These Healthcare Stocks: Encompass Health (EHC), Abivax SA Sponsored ADR (ABVX)

TIPRANKS
·
Jun 16

Barclays Keeps Their Buy Rating on Abivax SA Sponsored ADR (ABVX)

TIPRANKS
·
Jun 16

Movement Alert|Abivax S.A. Rises 5.03% in Regular Trading, Technical Rebound Continues as Phase 3 Safety Concerns Digested

Market Focus
·
Jun 16

Movement Alert|Abivax S.A. Falls 5.27% in Regular Trading, Phase 3 Trial Cancer Safety Concerns Compounded by Securities Fraud Investigation

Market Focus
·
Jun 10

Movement Alert|Abivax S.A. Falls 5.32% in Regular Trading, Phase 3 Trial Cancer Safety Concerns Continue to Weigh on Stock

Market Focus
·
Jun 08

Analysts Offer Insights on Healthcare Companies: Phibro Animal Health (PAHC) and Abivax SA Sponsored ADR (ABVX)

TIPRANKS
·
Jun 07

Movement Alert|Abivax S.A. Falls 5.49% in Regular Trading, Phase 3 Trial Cancer Case Safety Concerns Continue to Weigh on Shares

Market Focus
·
Jun 05

Movement Alert|Abivax S.A. Rises 5.65% in Regular Trading, Extending Rebound After Phase 3 Trial Cancer Scare Triggered 40%+ Selloff

Market Focus
·
Jun 04

This Is Why Abivax Stock (ABVX) Is Up Today

TIPRANKS
·
Jun 04

Abivax price target lowered to $136 from $176 at Wolfe Research

TIPRANKS
·
Jun 04

Abivax rises 14.1%

TIPRANKS
·
Jun 03

Movement Alert|Abivax S.A. Rises 16.03% in Regular Trading, Partial Rebound After Phase 3 Trial Cancer Cases Triggered 40% Plunge

Market Focus
·
Jun 03

Movement Alert|Abivax S.A. Rises 6.21% in Pre-Market Trading, Partial Rebound After Phase 3 Trial Cancer Concerns Triggered 40% Crash

Market Focus
·
Jun 03

Analysts Have Conflicting Sentiments on These Healthcare Companies: Abivax SA Sponsored ADR (ABVX), Bausch Health Companies (BHC) and Healthequity (HQY)

TIPRANKS
·
Jun 03

Movement Alert|Abivax S.A. Rises 5.28% Overnight, Partial Rebound After 40% Crash on Phase 3 Trial Cancer Safety Concerns

Market Focus
·
Jun 03

Movement Alert|Abivax S.A. Rises 5.12% in After-Hours Trading, Modest Rebound Following 40% Intraday Plunge on Phase 3 Cancer Safety Concerns

Market Focus
·
Jun 03

Top Midday Decliners

MT Newswires Live
·
Jun 03

Sector Update: Healthcare Stocks Fall in Afternoon Trading

MT Newswires Live
·
Jun 03